<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Neurosci.</abbrev-journal-title>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fnmol.2023.1092864</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Neuroscience</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Trait sensitivity to negative feedback in rats is associated with increased expression of serotonin 5-HT<sub>2A</sub> receptors in the ventral hippocampus</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Surowka</surname>
<given-names>Paulina</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/1071302/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noworyta</surname>
<given-names>Karolina</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Smaga</surname>
<given-names>Irena</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Filip</surname>
<given-names>Malgorzata</given-names>
</name>
<xref rid="aff2" ref-type="aff"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Rygula</surname>
<given-names>Rafal</given-names>
</name>
<xref rid="aff1" ref-type="aff"><sup>1</sup></xref>
<xref rid="c001" ref-type="corresp"><sup>&#x002A;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/159562/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Affective Cognitive Neuroscience Laboratory, Department of Pharmacology, Maj Institute of Pharmacology Polish Academy of Sciences</institution>, <addr-line>Krakow</addr-line>, <country>Poland</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Drug Addiction Pharmacology, Maj Institute of Pharmacology Polish Academy of Sciences</institution>, <addr-line>Krakow</addr-line>, <country>Poland</country></aff>
<author-notes>
<fn id="fn0001" fn-type="edited-by"><p>Edited by: Jolanta Dorszewska, Poznan University of Medical Sciences, Poland</p></fn>
<fn id="fn0002" fn-type="edited-by"><p>Reviewed by: Yan Li, Apellis Pharmaceuticals, United States; Heinrich S. Gompf, University of Massachusetts Medical School, United States; Virginie Rappeneau, Osnabr&#x00FC;ck University, Germany</p></fn>
<corresp id="c001">&#x002A;Correspondence: Rafal Rygula, &#x02709; <email>rygula@gmail.com</email></corresp>
<fn id="fn0003" fn-type="other"><p>This article was submitted to Brain Disease Mechanisms, a section of the journal Frontiers in Molecular Neuroscience</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>16</volume>
<elocation-id>1092864</elocation-id>
<history>
<date date-type="received">
<day>08</day>
<month>11</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2023 Surowka, Noworyta, Smaga, Filip and Rygula.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Surowka, Noworyta, Smaga, Filip and Rygula</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>One of the most important yet still underappreciated mechanisms of depression is distorted cognition, with aberrant sensitivity to negative feedback being one of the best-described examples. As serotonin has been identified as an important modulator of sensitivity to feedback and because the hippocampus has been implicated in the mediation of learning from positive and negative outcomes, the present study aimed to identify differences in the expression of various genes encoding 5-HT receptors in this brain region between the rats displaying trait sensitivity and insensitivity to negative feedback. The results demonstrated that trait sensitivity to negative feedback is associated with increased mRNA expression of the 5-HT2A receptors in the rat ventral hippocampus (vHipp). Further analysis revealed that this increased expression might be modulated epigenetically by miRNAs with a high target score for the <italic>Htr2a</italic> gene (<italic>miR-16-5p</italic> and <italic>miR-15b-5p</italic>). Additionally, although not confirmed at the protein level, trait sensitivity to negative feedback was associated with decreased expression of mRNA encoding the 5-HT7 receptor in the dorsal hippocampus (dHipp). We observed no statistically significant intertrait differences in the expression of the <italic>Htr1a</italic>, <italic>Htr2c</italic>, and <italic>Htr7</italic> genes in the vHipp and no statistically significant intertrait differences in the expression of the <italic>Htr1a</italic>, <italic>Htr2a</italic>, and <italic>Htr2c</italic> genes in the dHipp of the tested animals. These results suggest that resilience to depression manifested by reduced sensitivity to negative feedback may be mediated <italic>via</italic> these receptors.</p>
</abstract>
<kwd-group>
<kwd>feedback sensitivity</kwd>
<kwd>animal model</kwd>
<kwd>5HT2A</kwd>
<kwd>epigenetic</kwd>
<kwd>rat</kwd>
</kwd-group>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="8"/>
<word-count count="5369"/>
</counts>
</article-meta>
</front>
<body>
<sec id="sec1" sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Depression is one of the most common psychiatric disorders and the leading cause of disability in the 21st century, affecting an estimated 350 million people worldwide (<xref ref-type="bibr" rid="ref16">Mulder, 2002</xref>; <xref ref-type="bibr" rid="ref7">Belzung et al., 2015</xref>). One of the most important yet still underappreciated mechanisms of depression is distorted cognition, with aberrant sensitivity to negative feedback (NF) being one of the best-described examples (<xref ref-type="bibr" rid="ref5">Beck, 1967</xref>, <xref ref-type="bibr" rid="ref6">2008</xref>). This phenomenon manifests itself as an overreaction to negative events (catastrophic reaction to perceived failure) and reduced ability to ignore them (<xref ref-type="bibr" rid="ref4">Beats et al., 1996</xref>; <xref ref-type="bibr" rid="ref10">Elliott et al., 1997</xref>; <xref ref-type="bibr" rid="ref17">Murphy et al., 2003</xref>; <xref ref-type="bibr" rid="ref34">Taylor Tavares et al., 2008</xref>). The inter-individual variability in the sensitivity to NF may represent various types of potential vulnerability to depression and antidepressant treatment (<xref ref-type="bibr" rid="ref26">Rygula et al., 2018</xref>; <xref ref-type="bibr" rid="ref32">Surowka et al., 2022</xref>). Thanks to the implementation of the preclinical version of the probabilistic reversal learning (PRL) test, it has become possible to investigate sensitivity to NF in an animal model. Previous research revealed that trait sensitivity to NF is a stable and enduring behavioural trait in rats (<xref ref-type="bibr" rid="ref21">Noworyta-Sokolowska et al., 2019</xref>), which interacts with antidepressant drugs (<xref ref-type="bibr" rid="ref19">Noworyta et al., 2021</xref>). As serotonin (5-HT) has been identified as an important modulator of sensitivity to NF (<xref ref-type="bibr" rid="ref19">Noworyta et al., 2021</xref>) and because the hippocampus (Hipp) has been implicated in the mediation of learning from feedback (<xref ref-type="bibr" rid="ref35">Vila-Ballo et al., 2017</xref>), the present study aimed to identify differences in the expression of various genes encoding 5-HT receptors in the Hipp between rats displaying trait sensitivity and insensitivity to NF.</p>
<p>To accomplish this, a series of PRL tests were used. We classified each rat as sensitive or insensitive to NF, and subsequently, using reverse transcription-quantitative polymerase chain reaction (RT&#x2013;qPCR), we analysed intertrait differences in the expression of the <italic>Htr1a</italic>, <italic>Htr2a</italic>, <italic>Htr2c</italic>, and <italic>Htr7</italic> genes in the ventral Hipp (vHipp) and dorsal Hipp (dHipp) of tested animals. After observing significant differences in mRNA levels, we validated these differences at the protein level. Additionally, to identify potential epigenetic mechanisms that could be involved in the observed differences in the expression of 5-HT receptors, we examined relative amounts of microRNAs (miRNAs) for molecules with high target scores for the <italic>Htr2a</italic> gene (<italic>miR-16-5p</italic> and <italic>miR-15b-5p</italic>) in the vHipp, where the altered mRNA and protein levels were observed.</p>
</sec>
<sec id="sec2" sec-type="materials|methods">
<label>2.</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1.</label>
<title>Subjects and housing</title>
<p>We used 17 male Sprague&#x2013;Dawley rats (Charles River, Germany) weighing on arrival 176&#x2013;200&#x2009;g, which corresponds to the age of 6&#x2013;8&#x2009;weeks and is the standard age in this type of experiment. The sex of animals has been chosen to enable comparison of the results with previous data from ours and other laboratories, which, in the overwhelming majority, have been generated using male rats (for review see (<xref ref-type="bibr" rid="ref26">Rygula et al., 2018</xref>)). Animals were group-housed (four animals per cage) in an enriched environment (plastic pipes 25&#x2009;cm long) under controlled temperature (21&#x2009;&#x00B1;&#x2009;1&#x00B0;C) and humidity (40&#x2013;50%) and a 12&#x2009;h light/dark cycle (lights on at 7: 00&#x2009;AM). Throughout the experiment, rats were mildly food restricted to 85% of their free-feeding weight (according to the normal growth curve recommended by the laboratory rodent supplier - Charles River Research Models and Services Catalogue) by providing 15&#x2009;g of food pellets/rat/day (standard laboratory chow). The food restriction used in our study is a standard and broadly applied procedure in experiments using operant conditioning techniques allowing to maintain motivation and performance of the experimental animals (<xref ref-type="bibr" rid="ref27">Rygula et al., 2013</xref>; <xref ref-type="bibr" rid="ref9">Cieslik et al., 2022</xref>; <xref ref-type="bibr" rid="ref32">Surowka et al., 2022</xref>). Water was always available <italic>ad libitum</italic>. All behavioural procedures were performed during the light phase of the light/dark cycle.</p>
</sec>
<sec id="sec4">
<label>2.2.</label>
<title>Experimental apparatus</title>
<p>The PRL tests were conducted in operant conditioning chambers (Med Associates; St Albans, Vermont, USA) enclosed within a sound-attenuating box. Each chamber was equipped with a fan, house light, speaker, a food dispenser set to deliver a sucrose pellet (Dustless Precision Pellets, 45&#x2009;mg; Bio-Serv, New Jersey, USA), and two retractable levers located at the sides of the feeder.</p>
</sec>
<sec id="sec5">
<label>2.3.</label>
<title>Measuring sensitivity to feedback using the PRL test</title>
<p>After the initial instrumental training described in detail elsewhere (<xref ref-type="bibr" rid="ref26">Rygula et al., 2018</xref>) and upon reaching the initial training criterion of less than 7.5% omissions on each lever (i.e., less than 15% total omissions but equally distributed between the 2 levers) for 3 consecutive training days, the rats were trained in the PRL paradigm. In brief, each PRL training session lasted until the completion of 200 trials, and each trial lasted for a maximum of 22&#x2009;s. The start of a trial was signalled by the house light, which remained on until the end of the trial. Two seconds after the trial had started, both levers were presented, and one of them was randomly assigned as the &#x201C;correct&#x201D; lever, which delivered a reward (one sucrose pellet) 80% of the times it was pressed. A press on the other lever, the &#x201C;incorrect&#x201D; lever, would result in a rewarding outcome only 20% of the times it was pressed. No response in 10&#x2009;s triggered the intertrial interval (ITI) and was counted as an omission. During the ITI, both levers remained retracted, and the house light was turned off. The same ITI directly followed an unrewarded outcome, i.e., no reward on 20% of the &#x201C;correct&#x201D; and 80% of the &#x201C;incorrect&#x201D; lever presses. After every 8 consecutive &#x201C;correct&#x201D; lever presses (regardless of the outcome), the criterion for the reversal of the outcome probabilities was reached. The previously &#x201C;correct&#x201D; lever now became &#x201C;incorrect&#x201D; and vice versa. This pattern was followed until the end of the session. The PRL training phase was repeated daily until the individual animals achieved sufficient performance levels. The criteria to be met were a minimum of 3 reversals completed during 3 consecutive training sessions, with less than 15% omissions per session.</p>
</sec>
<sec id="sec6">
<label>2.4.</label>
<title>Parameters measured in the PRL test</title>
<p>To measure rats&#x2019; sensitivity to NF (measured as the ability of animals to ignore infrequent and misleading lack of reward), their decisions were monitored on a trial-by-trial basis. Unrewarded outcomes on the &#x201C;correct&#x201D; lever, after which an animal decided to switch levers (probabilistic lose-shifts), were scored and expressed as a ratio of all unrewarded outcomes on that lever. Additional measured parameters included the proportion of all rewarded outcomes followed by a decision to stay with the lever that delivered them (win-stay behaviours), and the number of reversals completed during the test, which relies on the ability to both suppress previously rewarded action and engage in previously unrewarded actions, and was used as a measure of the animal&#x2019;s performance (<xref ref-type="bibr" rid="ref3">Bari et al., 2010</xref>).</p>
</sec>
<sec id="sec7">
<label>2.5.</label>
<title>Feedback sensitivity screening</title>
<p>After achieving a stable performance in the PRL test (a minimum of 3 reversals and less than 15% omissions in three consecutive sessions), animals were subsequently tested in 10 consecutive PRL tests over 10&#x2009;days. Based on this &#x201C;NF sensitivity screening,&#x201D; the rats were divided using the median split into the NF-insensitive and NF-sensitive groups. The division was made based on the average ratio of lever changes following misleading unrewarded outcomes (probabilistic lose-shifts) made by the animals across all 10 screening tests. Because the results of our previous studies have clearly indicated that such a dichotomous categorization based on median split is well suited to investigate NF sensitivity as a stable and enduring cognitive trait in rats (<xref ref-type="bibr" rid="ref28">Rygula and Popik, 2016</xref>; <xref ref-type="bibr" rid="ref21">Noworyta-Sokolowska et al., 2019</xref>; <xref ref-type="bibr" rid="ref33">Surowka et al., 2020</xref>; <xref ref-type="bibr" rid="ref20">Noworyta and Rygula, 2021</xref>), this method of data analysis has been extended to the present research. The number of screening days following meeting the performance criterion was also based on the results of our previous experiments (<xref ref-type="bibr" rid="ref28">Rygula and Popik, 2016</xref>; <xref ref-type="bibr" rid="ref21">Noworyta-Sokolowska et al., 2019</xref>; <xref ref-type="bibr" rid="ref33">Surowka et al., 2020</xref>; <xref ref-type="bibr" rid="ref20">Noworyta and Rygula, 2021</xref>).</p>
</sec>
<sec id="sec8">
<label>2.6.</label>
<title>Brain tissue isolation</title>
<p>After decapitation, the brains were quickly removed, frozen on dry ice and stored at-80&#x00B0;C until processed. The tissue of the dorsal and ventral hippocampi was manually isolated using sterile tweezers by a person experienced in this type of procedure, and according to The Rat Brain Atlas (<xref ref-type="bibr" rid="ref22">Paxinos and Watson, 1998</xref>). The structures were collected between coordinates from the bregma in mm-dHipp (CA1): AP&#x2009;~&#x2009;&#x2212; 2.6 to &#x2212;5.2&#x2009;mm, ML&#x2009;~&#x2009;0&#x2009;&#x00B1;&#x2009;5&#x2009;mm, DV&#x2009;~&#x2009;3&#x2013;4.5&#x2009;mm; vHipp (CA3): AP&#x2009;~&#x2009;&#x2212; 5.2 to &#x2212;6.04&#x2009;mm, ML ~4&#x2009;&#x00B1;&#x2009;6&#x2009;mm, DV ~4.5&#x2013;9&#x2009;mm (<xref ref-type="bibr" rid="ref22">Paxinos and Watson, 1998</xref>).</p>
</sec>
<sec id="sec9">
<label>2.7.</label>
<title>RNA isolation</title>
<p>The RNA Mini Kit (A&#x0026;A Biotechnology, Gda&#x0144;sk, Poland) was used for RNA extraction. The quantity of the RNA was checked with a NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE, USA).</p>
</sec>
<sec id="sec10">
<label>2.8.</label>
<title>RT&#x2013;qPCR for gene expression analysis</title>
<p>The High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, Waltham, MA, USA, Life Technologies, Waltham, MA, USA) was used for reverse transcription into cDNA. RT&#x2013;qPCR was performed by using Quant Studio 3 (Thermo Fisher Scientific, Life Technologies, Waltham, MA, USA) and TaqMan Gene Expression Assays (Applied Biosystems, San Francisco, CA, USA) for <italic>Htr1a</italic> (Rn00561409_s1), <italic>Htr2a</italic> (Rn00568473_m1), <italic>Htr2c</italic> (Rn00562748_m1), and <italic>Htr7</italic> (Rn0056048_m1). The PCR conditions were described previously by <xref ref-type="bibr" rid="ref13">Gawlinski et al. (2021)</xref>. The relative level of mRNA was assessed using the comparative CT method (2<sup>&#x2212;&#x0394;&#x0394;Ct</sup>) and normalized to the level of hypoxanthine phosphoribosyltransferase 1 (<italic>Hprt1</italic>), a housekeeping control (Rn01527840_m1).</p>
</sec>
<sec id="sec11">
<label>2.9.</label>
<title>RT&#x2013;qPCR for miRNA expression analysis</title>
<p>Total RNA (20&#x2009;ng) and miRNA-specific stem&#x2013;loop RT primers (Applied Biosystems, San Francisco, CA, USA) were used for the reverse transcription reactions of miRNA. The cDNAs were then synthesized with the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems, San Francisco, CA, USA) according to the manufacturer&#x2019;s protocol. RT&#x2013;qPCR was performed with TaqMan MicroRNA assays (Applied Biosystems, San Francisco, CA, USA) to analyse the expression of the following mature miRNAs: <italic>miR-16-5p</italic> (assay ID: 000391) and <italic>miR-15b-5p</italic> (assay ID: 000390). The relative level of miRNA was assessed using the comparative CT method (2<sup>&#x2212;&#x0394;&#x0394;Ct</sup>) and normalized to the level of the U6 small nuclear RNA (U6 snRNA). One sample from this analysis was excluded due to technical problems.</p>
</sec>
<sec id="sec12">
<label>2.10.</label>
<title>Enzyme-linked immunosorbent assay (ELISA)</title>
<p>In the next step, the levels of proteins encoded by the genes that were differentially expressed in rats classified as NF-sensitive and NF-insensitive were measured using ELISA kits (Bioassay Technology Laboratory, Shanghai, China). Quantities of the 5-HT<sub>2A</sub> (#CAT E1825Ra) and 5-HT<sub>7</sub> (#CAT E3324Ra) receptors were measured according to the manufacturer&#x2019;s protocol. Duplicates of each sample and series of standards were transferred to ELISA plates. The absorbance was measured at a wavelength of <italic>&#x03BB;</italic> =&#x2009;450&#x2009;nm using a Multiskan Spectrum spectrophotometer (Thermo LabSystems, Philadelphia, PA, USA). The concentration of proteins was calculated from a standard curve and expressed as ng/mg of protein. For total protein measurement, a bicinchoninic acid assay (BCA) protein assay kit (Serva, Heidelberg, Germany) was used.</p>
</sec>
<sec id="sec13">
<label>2.11.</label>
<title>Statistical analyses</title>
<p>The data were analysed using GraphPad Prism (version 8.0.1). The distribution of the experimental data was tested using the Kolmogorov&#x2013;Smirnov test. The screening data were analyzed using one-way (for the whole cohort) or two-way (for the animals classified as sensitive and insensitive to NF) ANOVAs with repeated measures and the within-subject factor of test day (10 levels: test day 1 &#x2026; test day 10) and between-subject factor of NF sensitivity (2 levels: sensitive and insensitive). For pairwise comparisons, the values were adjusted using the Sidak correction (<xref ref-type="bibr" rid="ref14">Howell, 1997</xref>). In molecular studies, statistical analyses were performed using a t-Student test. Additionally a Pearson correlation coefficients were computed to assess the linear relationship between the mRNA levels of all investigated genes, and between the levels of miRNAs and the sensitivity to NF (proportion of lose-shift behavior). The tests of significance were performed at <italic>&#x03B1;</italic> =&#x2009;0.05.</p>
</sec>
</sec>
<sec id="sec14" sec-type="results">
<label>3.</label>
<title>Results</title>
<p>All animals fulfilled the training criteria and qualified for PRL screening.</p>
<sec id="sec15">
<label>3.1.</label>
<title>NF sensitivity screening</title>
<p>For the animals classified as NF insensitive, the average proportion of lose-shift responses following misleading NF ranged from 0.385 to 0.505, with an average of 0.454&#x2009;&#x00B1;&#x2009;0.042. For those classified as NF sensitive, the average proportion of probabilistic lose-shift responses ranged from 0.523 to 0.740, with an average of 0.606&#x2009;&#x00B1;&#x2009;0.013. The sensitivity to NF in both subgroups was stable across 10 consecutive screening days {nonsignificant screening Day x NF sensitivity interaction [<italic>F</italic>(9, 135)&#x2009;=&#x2009;0.853, <italic>p</italic> =&#x2009;0.569, <xref rid="fig1" ref-type="fig">Figure 1A</xref>]}. There were no significant inter-trait differences neither in the proportion of win-stay behaviours [<italic>F</italic>(1, 15)&#x2009;=&#x2009;0.034, <italic>p</italic> =&#x2009;0.977, <xref rid="fig1" ref-type="fig">Figure 1B</xref>] nor in the number of reversals [<italic>F</italic>(1, 15)&#x2009;=&#x2009;0.353, <italic>p</italic> =&#x2009;0.561, <xref rid="fig1" ref-type="fig">Figure 1C</xref>].</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Negative feedback (NF) sensitivity screening. <bold>(A)</bold> The average proportion of lose-shift behaviours following misleading negative feedback in rats classified as trait NF insensitive (open circles, <italic>N</italic> =&#x2009;8) and trait NF sensitive (filled circles, <italic>N</italic> =&#x2009;9) across all 10 screening probabilistic reversal learning (PRL) tests; <bold>(B)</bold> The average proportion of win-stay behaviours following positive feedback in rats classified as trait NF insensitive (open circles, <italic>N</italic> =&#x2009;8) and trait NF sensitive (filled circles, <italic>N</italic> =&#x2009;9) across all 10 screening PRL tests. <bold>(C)</bold> The average number of reversals in rats classified as trait NF insensitive (open circles, <italic>N</italic> =&#x2009;8) and trait NF sensitive (filled circles, <italic>N</italic> =&#x2009;9) across all 10 screening PRL tests.</p>
</caption>
<graphic xlink:href="fnmol-16-1092864-g001.tif"/>
</fig>
</sec>
<sec id="sec16">
<label>3.2.</label>
<title>mRNA levels</title>
<p>Because each RT&#x2013;qPCR reaction was performed separately, and because analysis of the correlation between the relative mRNA levels of all analyzed genes revealed no statistically significant correlations between them (see <xref ref-type="supplementary-material" rid="SM1">Supplementary Table S1</xref>), the intergroup differences between the NF sensitive and NF insensitive animals were analyzed using separate t-tests. In the vHipp of rats classified as NF sensitive, the mRNA level of <italic>Htr2a</italic> was statistically significantly higher than in the vHipp of rats classified as NF insensitive (<italic>t</italic> =&#x2009;2.886, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.011, <xref rid="fig2" ref-type="fig">Figure 2B</xref>). There was also a positive correlation between the sensitivity to NF (proportion of lose-shift behaviour) and the mRNA levels of <italic>Htr2a</italic> [<italic>r</italic>(15)&#x2009;=&#x2009;0.670, <italic>p</italic> =&#x2009;0.003]. There were no statistically significant intergroup differences in the mRNA levels of <italic>Htr1a</italic> (<italic>t</italic> =&#x2009;1.551, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.142, <xref rid="fig2" ref-type="fig">Figure 2A</xref>), <italic>Htr2c</italic> (<italic>t</italic> =&#x2009;1.969, df&#x2009;=&#x2009;14, <italic>p</italic> =&#x2009;0.069, <xref rid="fig2" ref-type="fig">Figure 2C</xref>), and <italic>Htr7</italic> (<italic>t</italic> =&#x2009;0.438, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.668, <xref rid="fig2" ref-type="fig">Figure 2D</xref>) in this region. The correlation between sensitivity to NF and the mRNA levels of <italic>Htr2c</italic> [<italic>r</italic>(14)&#x2009;=&#x2009;&#x2212;0.048, <italic>p</italic> =&#x2009;0.857], and <italic>Htr7</italic> [<italic>r</italic>(15)&#x2009;=&#x2009;&#x2212;0.048, <italic>p</italic> =&#x2009;0.857] was not significant. Interestingly, the mRNA levels of <italic>Htr1a</italic>, turned out to be also positively correlated with sensitivity to NF [<italic>r</italic>(15)&#x2009;=&#x2009;0.499, <italic>p</italic> =&#x2009;0.041].</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Analysis of the differences in the expression of serotonin 5-HT receptors in the ventral hippocampus (vHipp) and dorsal hippocampus (dHipp) of rats trait insensitive and trait sensitive to negative feedback (NF). Panels <bold>(A&#x2013;D)</bold> demonstrate the mRNA levels of genes encoding the Htr1a <bold>(A)</bold>, Htr2a <bold>(B)</bold>, Htr2c <bold>(C)</bold>, and Htr7 <bold>(D)</bold> serotonin receptors in the vHipp of trait NF-sensitive and trait NF-insensitive rats. Panels <bold>(E&#x2013;H)</bold> demonstrate the mRNA levels of genes encoding the Htr1a <bold>(E)</bold>, Htr2a <bold>(F)</bold>, Htr2c <bold>(G)</bold>, and Htr7 <bold>(H)</bold> serotonin receptors in the dHipp of trait NF-sensitive and trait NF-insensitive rats. Panels I and J demonstrate the protein levels of 5-HT<sub>2A</sub> receptors in the vHipp <bold>(I)</bold> and the protein levels of 5-HT<sub>7</sub> receptors in the dHipp <bold>(J)</bold> of trait NF-sensitive and trait NF-insensitive rats. Panels K and L demonstrate the levels of miR-16-5p <bold>(K)</bold> and miR-15b-5p <bold>(L)</bold> in the vHipp of trait NF-sensitive and trait NF-insensitive rats. Data are presented as the mean&#x2009;&#x00B1;&#x2009;SEM. &#x002A;<italic>p</italic> &#x003C;&#x2009;0.05; &#x002A;&#x002A;<italic>p</italic> &#x003C;&#x2009;0.01; &#x002A;&#x002A;&#x002A;<italic>p</italic> &#x003C;&#x2009;0.001 vs. the NF-sensitive group.</p>
</caption>
<graphic xlink:href="fnmol-16-1092864-g002.tif"/>
</fig>
<p>In the dHipp, the mRNA levels of <italic>Htr1a</italic> (<italic>t</italic> =&#x2009;1.155, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.266, <xref rid="fig2" ref-type="fig">Figure 2E</xref>), <italic>Htr2a</italic> (<italic>t</italic> =&#x2009;1.015, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.326, <xref rid="fig2" ref-type="fig">Figure 2F</xref>), and <italic>Htr2c</italic> (<italic>t</italic> =&#x2009;0.413, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.685, <xref rid="fig2" ref-type="fig">Figure 2G</xref>) did not significantly differ between the rats classified as NF sensitive and NF insensitive. The level of <italic>Htr7</italic> mRNA in the dHipp was significantly lower in rats classified as NF sensitive compared to their NF insensitive conspecifics (<italic>t</italic> =&#x2009;4.685, df&#x2009;=&#x2009;15, <italic>p</italic> &#x003C;&#x2009;0.001, <xref rid="fig2" ref-type="fig">Figure 2H</xref>). There was also a negative correlation between the sensitivity to NF (proportion of lose-shift behaviour) and the mRNA levels of <italic>Htr7</italic> [<italic>r</italic>(15)&#x2009;=&#x2009;&#x2212;0.529, <italic>p</italic> =&#x2009;0.029]. The correlation between sensitivity to NF and the mRNA levels of <italic>Htr1a</italic> [<italic>r</italic>(15)&#x2009;=&#x2009;&#x2212;0.200, <italic>p</italic> =&#x2009;0.443], <italic>Htr2a</italic> [<italic>r</italic>(15)&#x2009;=&#x2009;&#x2212;0.165, <italic>p</italic> =&#x2009;0.528], and <italic>Ht2c</italic> [<italic>r</italic>(15)&#x2009;=&#x2009;&#x2212;0.048, <italic>p</italic> =&#x2009;0.857] was not significant.</p>
</sec>
<sec id="sec17">
<label>3.3.</label>
<title>Protein levels</title>
<p>After observing significant differences in mRNA levels, these differences were validated at the protein level. Statistically significantly higher levels of the 5-HT<sub>2A</sub> receptors were detected in the vHipp (<italic>t</italic> =&#x2009;3.045, df&#x2009;=&#x2009;14, <italic>p</italic> =&#x2009;0.009) of rats classified as NF sensitive compared to their insensitive conspecifics (<xref rid="fig2" ref-type="fig">Figure 2I</xref>). Surprisingly, no significant intertrait differences in the 5-HT<sub>7</sub> receptor levels (<italic>t</italic> =&#x2009;0.941, df&#x2009;=&#x2009;15, <italic>p</italic> =&#x2009;0.362) were observed in the dHipp (<xref rid="fig2" ref-type="fig">Figure 2J</xref>).</p>
</sec>
<sec id="sec18">
<label>3.4.</label>
<title>miRNA levels</title>
<p>In the next step, the potential epigenetic mechanism of the observed differences in the expression of mRNA encoding the <italic>Htr2a</italic> gene in vHipp was evaluated by detecting miRNAs (<italic>miR-16-5p</italic> and <italic>miR-15b-5p)</italic>. The miRNA analyses revealed statistically significant lower levels of <italic>miR-16-5p</italic> (<italic>t</italic> =&#x2009;2.498, df&#x2009;=&#x2009;14 <italic>p</italic> =&#x2009;0.0256, <xref rid="fig2" ref-type="fig">Figure 2K</xref>) and <italic>miR-15b-5p</italic> (<italic>t</italic> =&#x2009;12.68, df&#x2009;=&#x2009;14, <italic>p</italic> &#x003C;&#x2009;0.0001, <xref rid="fig2" ref-type="fig">Figure 2L</xref>) in the vHipp of rats classified as NF sensitive compared to their NF-insensitive conspecifics. There was also a negative correlation between the sensitivity to NF (proportion of lose-shift behaviour) and the levels of <italic>miR-15b-5p</italic> [<italic>r</italic>(14)&#x2009;=&#x2009;&#x2212;0.725, <italic>p</italic> =&#x2009;0.002]. The correlation between sensitivity to NF and the levels of <italic>miR-16-5p</italic> was not significant [<italic>r</italic>(14)&#x2009;=&#x2009;&#x2212;0.390, <italic>p</italic> =&#x2009;0.136].</p>
</sec>
</sec>
<sec id="sec19" sec-type="discussions">
<label>4.</label>
<title>Discussion</title>
<p>The results of the present study demonstrated that trait sensitivity to NF is associated with increased mRNA expression of 5-HT<sub>2A</sub> receptors in the rat vHipp. Further analysis revealed that this increased expression might be modulated epigenetically by miRNAs with a high target score for the <italic>Htr2a</italic> gene (<italic>miR-16-5p</italic> and <italic>miR-15b-5p</italic>). Additionally, although not confirmed at the protein level, trait sensitivity to NF was associated with decreased expression of mRNA encoding the 5-HT<sub>7</sub> receptor in the dHipp. We observed no statistically significant intertrait differences in the expression of the <italic>Htr1a</italic>, <italic>Htr2c</italic>, and <italic>Htr7</italic> genes in the vHipp and no statistically significant intertrait differences in the expression of the <italic>Htr1a</italic>, <italic>Htr2a,</italic> and <italic>Htr2c</italic> genes in the dHipp of the tested animals.</p>
<p>Several previous studies have implicated 5-HT in the modulation of sensitivity to NF. Reports suggest that increasing 5-HT transmission leads to reduced sensitivity to aversive outcomes, whereas decreasing 5-HT transmission, by way of either upregulation of the 5-HT transporter (SERT), presynaptic receptor stimulation, or acute tryptophan depletion, leads to increased sensitivity to NF [reviewed by <xref ref-type="bibr" rid="ref26">Rygula et al. (2018)</xref>]. In humans, studies by <xref ref-type="bibr" rid="ref8">Chamberlain et al. (2006)</xref> and <xref ref-type="bibr" rid="ref30">Skandali et al. (2018)</xref> showed that low, acute doses of the selective 5-HT reuptake inhibitors (SSRIs) citalopram and escitalopram, which were postulated to downregulate 5-HT transmission <italic>via</italic> presynaptic 5-HT autoreceptors, increased the sensitivity to NF in the PRL task. The results from animal models complement these observations. <xref ref-type="bibr" rid="ref3">Bari et al. (2010)</xref> repeated the effect observed by Chamberlain and collaborators in humans using a preclinical version of the PRL test in rats treated with citalopram. A study by <xref ref-type="bibr" rid="ref23">Phillips et al. (2018)</xref> revealed that administration of the 5-HT<sub>2C</sub> receptor agonist (WAY 163909) resulted in a decreased sensitivity to NF in rats. The involvement of 5-HT<sub>2A</sub> receptors in the mediation of NF has been demonstrated in the past only once by <xref ref-type="bibr" rid="ref1">Amodeo et al. (2014)</xref>. In this study, a 5-HT<sub>2A</sub> receptor antagonist (M100907) reduced the number of regressive errors in probabilistic reversal learning, which can be interpreted as a reduction in sensitivity to NF. This result is consistent with our observation that low sensitivity to NF is associated with low expression of 5-HT<sub>2A</sub> receptors in the rat vHipp. Interestingly, it seems that the difference in the expression of 5-HT<sub>2A</sub> receptors observed between NF-sensitive and NF-insensitive animals is mediated by posttranslational and epigenetic mechanisms associated with differences in the expression of the miRNA with a high target score for the <italic>Htr2a</italic> gene (<italic>miR-16-5p</italic> and <italic>miR-15b-5p</italic>). This absolutely novel result, although pioneering, is not surprising, as it has been shown previously that coping with the stress response is associated with changes in the expression of various miRNAs in the Hipp (<xref ref-type="bibr" rid="ref11">Fanselow and Dong, 2010</xref>; <xref ref-type="bibr" rid="ref12">Floriou-Servou et al., 2018</xref>). The reduced expression of <italic>miR-16-5p</italic> and <italic>miR-15b-5p</italic> observed in our study in rats classified as sensitive to NF, which was inversely correlated with the upregulation of <italic>Htr2a</italic> gene expression, was also reported in people suffering from depression, in whom reduced levels of <italic>miR-16</italic> were observed in the cerebrospinal fluid (<xref ref-type="bibr" rid="ref2">Artigas, 2013</xref>; <xref ref-type="bibr" rid="ref31">Song et al., 2015</xref>).</p>
<p>Considering that trait sensitivity to feedback can modulate the effects of the SSRI escitalopram (<xref ref-type="bibr" rid="ref20">Noworyta and Rygula, 2021</xref>) and that 5-HT<sub>2A</sub> receptor inactivation potentiates the acute antidepressant-like activity of this drug (<xref ref-type="bibr" rid="ref24">Quesseveur et al., 2012</xref>), the results of our study constitute a matching piece of the puzzle. Namely, the high availability of the 5-HT<sub>2A</sub> receptors revealed by our study in animals classified as sensitive to NF suggests that vulnerability to depression manifested by increased sensitivity to NF in humans (<xref ref-type="bibr" rid="ref10">Elliott et al., 1997</xref>; <xref ref-type="bibr" rid="ref17">Murphy et al., 2003</xref>), and determined by this sensitivity in rats (<xref ref-type="bibr" rid="ref32">Surowka et al., 2022</xref>) may be mediated <italic>via</italic> these receptors. This finding also suggests the involvement of these receptors in the feedback sensitivity-dependent differences in the effects of acute escitalopram treatment on anxiety-like behaviours described by <xref ref-type="bibr" rid="ref20">Noworyta and Rygula (2021)</xref>.</p>
<p>Given the functional dissociation between the hippocampal regions, where the dHipp performs primarily cognitive functions while the vHipp relates to stress, emotion and affect (<xref ref-type="bibr" rid="ref15">Moser and Moser, 1998</xref>; <xref ref-type="bibr" rid="ref11">Fanselow and Dong, 2010</xref>), it is possible that specific changes in the expression of <italic>Htr2a</italic> and <italic>Htr7</italic> in these distinct subregions may serve very different functions. Further, pharmacologically targeted studies, should confirm the exact contribution of the mentioned receptors, along the dorsal&#x2013;ventral axis of the Hipp, to sensitivity to NF and in depression itself. Moreover, although the 5-HT genes investigated in the present study have been choosen based on the previous reports indicating their involvement in the sensitivity to feedback, depressive disorder or antidepressant therapy (<xref ref-type="bibr" rid="ref29">Savitz et al., 2009</xref>; <xref ref-type="bibr" rid="ref1">Amodeo et al., 2014</xref>; <xref ref-type="bibr" rid="ref18">Nautiyal and Hen, 2017</xref>; <xref ref-type="bibr" rid="ref23">Phillips et al., 2018</xref>; <xref ref-type="bibr" rid="ref25">Raval et al., 2021</xref>), one cannot exclude involvement of the other 5-HT receptors (5-HT<sub>1b</sub>, 5-HT<sub>1d</sub>, 5-HT<sub>2B</sub>, 5-HT<sub>3</sub>, 5-HT<sub>4</sub>, 5-HT<sub>6</sub>) in sensitivity to negative feedback. Further studies should address this question, and are needed to determine whether the 5-HT<sub>2A</sub>-dependent effects of trait sensitivity to NF on the efficacy of antidepressant treatment with SSRIs are specific to the Hipp or also occur in other brain regions.</p>
</sec>
<sec id="sec20" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref rid="sec25" ref-type="sec">Supplementary material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="sec21">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by All experiments were conducted following the European Union guidelines for the care and use of laboratory animals (2010/63/EU). Experimental protocols were reviewed and approved by the 2nd Local Institutional Animal Care and Use Committee at the Maj Institute of Pharmacology Polish Academy of Sciences in Krakow (Permission no. 242/2017).</p>
</sec>
<sec id="sec22">
<title>Author contributions</title>
<p>All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec id="sec23" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by the Polish National Science Centre (Research grants 2018/31/B/NZ7/03690 to RR, and 2016/23/B/NZ4/01562 to RR) and by the statutory funds of the Maj Institute of Pharmacology Polish Academy of Sciences.</p>
</sec>
<sec id="conf1" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="sec100" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="sec25" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fnmol.2023.1092864/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fnmol.2023.1092864/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Table_1.DOCX" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amodeo</surname> <given-names>D. A.</given-names></name> <name><surname>Jones</surname> <given-names>J. H.</given-names></name> <name><surname>Sweeney</surname> <given-names>J. A.</given-names></name> <name><surname>Ragozzino</surname> <given-names>M. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Risperidone and the 5-HT2A receptor antagonist M100907 improve probabilistic reversal learning in BTBR T + tf/J mice</article-title>. <source>Autism Res.</source> <volume>7</volume>, <fpage>555</fpage>&#x2013;<lpage>567</lpage>. doi: <pub-id pub-id-type="doi">10.1002/aur.1395</pub-id>, PMID: <pub-id pub-id-type="pmid">24894823</pub-id></citation></ref>
<ref id="ref2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Artigas</surname> <given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title>Serotonin receptors involved in antidepressant effects</article-title>. <source>Pharmacol. Ther.</source> <volume>137</volume>, <fpage>119</fpage>&#x2013;<lpage>131</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pharmthera.2012.09.006</pub-id></citation></ref>
<ref id="ref3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bari</surname> <given-names>A.</given-names></name> <name><surname>Theobald</surname> <given-names>D. E.</given-names></name> <name><surname>Caprioli</surname> <given-names>D.</given-names></name> <name><surname>Mar</surname> <given-names>A. C.</given-names></name> <name><surname>Aidoo-Micah</surname> <given-names>A.</given-names></name> <name><surname>Dalley</surname> <given-names>J. W.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title>Serotonin modulates sensitivity to reward and negative feedback in a probabilistic reversal learning task in rats</article-title>. <source>Neuropsychopharmacology</source> <volume>35</volume>, <fpage>1290</fpage>&#x2013;<lpage>1301</lpage>. doi: <pub-id pub-id-type="doi">10.1038/npp.2009.233</pub-id>, PMID: <pub-id pub-id-type="pmid">20107431</pub-id></citation></ref>
<ref id="ref4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beats</surname> <given-names>B. C.</given-names></name> <name><surname>Sahakian</surname> <given-names>B. J.</given-names></name> <name><surname>Levy</surname> <given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed</article-title>. <source>Psychol. Med.</source> <volume>26</volume>, <fpage>591</fpage>&#x2013;<lpage>603</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0033291700035662</pub-id>, PMID: <pub-id pub-id-type="pmid">8733217</pub-id></citation></ref>
<ref id="ref5"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Beck</surname> <given-names>A. T.</given-names></name></person-group> (<year>1967</year>). <source>Depression: Clinical, Experimental, and Theoretical Aspects</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>Harper and Row</publisher-name>.</citation></ref>
<ref id="ref6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname> <given-names>A. T.</given-names></name></person-group> (<year>2008</year>). <article-title>The evolution of the cognitive model of depression and its neurobiological correlates</article-title>. <source>Am. J. Psychiatry</source> <volume>165</volume>, <fpage>969</fpage>&#x2013;<lpage>977</lpage>. doi: <pub-id pub-id-type="doi">10.1176/appi.ajp.2008.08050721</pub-id>, PMID: <pub-id pub-id-type="pmid">18628348</pub-id></citation></ref>
<ref id="ref7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belzung</surname> <given-names>C.</given-names></name> <name><surname>Willner</surname> <given-names>P.</given-names></name> <name><surname>Philippot</surname> <given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Depression: from psychopathology to pathophysiology</article-title>. <source>Curr. Opin. Neurobiol.</source> <volume>30</volume>, <fpage>24</fpage>&#x2013;<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.conb.2014.08.013</pub-id></citation></ref>
<ref id="ref8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chamberlain</surname> <given-names>S. R.</given-names></name> <name><surname>Muller</surname> <given-names>U.</given-names></name> <name><surname>Blackwell</surname> <given-names>A. D.</given-names></name> <name><surname>Clark</surname> <given-names>L.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name> <name><surname>Sahakian</surname> <given-names>B. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Neurochemical modulation of response inhibition and probabilistic learning in humans</article-title>. <source>Science</source> <volume>311</volume>, <fpage>861</fpage>&#x2013;<lpage>863</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.1121218</pub-id>, PMID: <pub-id pub-id-type="pmid">16469930</pub-id></citation></ref>
<ref id="ref9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cieslik</surname> <given-names>A.</given-names></name> <name><surname>Noworyta</surname> <given-names>K.</given-names></name> <name><surname>Rygula</surname> <given-names>R.</given-names></name></person-group> (<year>2022</year>). <article-title>Trait sensitivity to negative feedback determines the intensity of compulsive alcohol seeking and taking in male rats</article-title>. <source>J. Psychiatry Neurosci.</source> <volume>47</volume>, <fpage>E252</fpage>&#x2013;<lpage>e262</lpage>. doi: <pub-id pub-id-type="doi">10.1503/jpn.210220</pub-id>, PMID: <pub-id pub-id-type="pmid">35820699</pub-id></citation></ref>
<ref id="ref10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elliott</surname> <given-names>R.</given-names></name> <name><surname>Sahakian</surname> <given-names>B. J.</given-names></name> <name><surname>Herrod</surname> <given-names>J. J.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name> <name><surname>Paykel</surname> <given-names>E. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Abnormal response to negative feedback in unipolar depression: evidence for a diagnosis specific impairment</article-title>. <source>J. Neurol. Neurosurg. Psychiatry</source> <volume>63</volume>, <fpage>74</fpage>&#x2013;<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1136/jnnp.63.1.74</pub-id>, PMID: <pub-id pub-id-type="pmid">9221971</pub-id></citation></ref>
<ref id="ref11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fanselow</surname> <given-names>M. S.</given-names></name> <name><surname>Dong</surname> <given-names>H. W.</given-names></name></person-group> (<year>2010</year>). <article-title>Are the dorsal and ventral hippocampus functionally distinct structures?</article-title> <source>Neuron</source> <volume>65</volume>, <fpage>7</fpage>&#x2013;<lpage>19</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuron.2009.11.031</pub-id>, PMID: <pub-id pub-id-type="pmid">20152109</pub-id></citation></ref>
<ref id="ref12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floriou-Servou</surname> <given-names>A.</given-names></name> <name><surname>Von Ziegler</surname> <given-names>L.</given-names></name> <name><surname>Stalder</surname> <given-names>L.</given-names></name> <name><surname>Sturman</surname> <given-names>O.</given-names></name> <name><surname>Privitera</surname> <given-names>M.</given-names></name> <name><surname>Rassi</surname> <given-names>A.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Distinct proteomic, transcriptomic, and epigenetic stress responses in dorsal and ventral hippocampus</article-title>. <source>Biol. Psychiatry</source> <volume>84</volume>, <fpage>531</fpage>&#x2013;<lpage>541</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopsych.2018.02.003</pub-id>, PMID: <pub-id pub-id-type="pmid">29605177</pub-id></citation></ref>
<ref id="ref13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gawlinski</surname> <given-names>D.</given-names></name> <name><surname>Gawlinska</surname> <given-names>K.</given-names></name> <name><surname>Smaga</surname> <given-names>I.</given-names></name></person-group> (<year>2021</year>). <article-title>Maternal high-fat diet modulates Cnr1 gene expression in male rat offspring</article-title>. <source>Nutrients</source> <volume>13</volume>:<fpage>2885</fpage>. doi: <pub-id pub-id-type="doi">10.3390/nu13082885</pub-id>, PMID: <pub-id pub-id-type="pmid">34445045</pub-id></citation></ref>
<ref id="ref14"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Howell</surname> <given-names>D. C.</given-names></name></person-group> (<year>1997</year>). <source>Statistical Methods for Psychology</source>. <publisher-name>Wadsworth</publisher-name>, <publisher-loc>Belmont, CA</publisher-loc>.</citation></ref>
<ref id="ref15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname> <given-names>M. B.</given-names></name> <name><surname>Moser</surname> <given-names>E. I.</given-names></name></person-group> (<year>1998</year>). <article-title>Functional differentiation in the hippocampus</article-title>. <source>Hippocampus</source> <volume>8</volume>, <fpage>608</fpage>&#x2013;<lpage>619</lpage>. doi: <pub-id pub-id-type="doi">10.1002/(SICI)1098-1063(1998)8:6&#x003C;608::AID-HIPO3&#x003E;3.0.CO;2-7</pub-id></citation></ref>
<ref id="ref16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulder</surname> <given-names>R. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Personality pathology and treatment outcome in major depression: a review</article-title>. <source>Am. J. Psychiatry</source> <volume>159</volume>, <fpage>359</fpage>&#x2013;<lpage>371</lpage>. doi: <pub-id pub-id-type="doi">10.1176/appi.ajp.159.3.359</pub-id></citation></ref>
<ref id="ref17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname> <given-names>F. C.</given-names></name> <name><surname>Michael</surname> <given-names>A.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name> <name><surname>Sahakian</surname> <given-names>B. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Neuropsychological impairment in patients with major depressive disorder: the effects of feedback on task performance</article-title>. <source>Psychol. Med.</source> <volume>33</volume>, <fpage>455</fpage>&#x2013;<lpage>467</lpage>. doi: <pub-id pub-id-type="doi">10.1017/S0033291702007018</pub-id>, PMID: <pub-id pub-id-type="pmid">12701666</pub-id></citation></ref>
<ref id="ref18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nautiyal</surname> <given-names>K. M.</given-names></name> <name><surname>Hen</surname> <given-names>R.</given-names></name></person-group> (<year>2017</year>). <article-title>Serotonin receptors in depression: from A to B</article-title>. <source>F1000Res</source> <volume>6</volume>:<fpage>123</fpage>. doi: <pub-id pub-id-type="doi">10.12688/f1000research.9736.1</pub-id>, PMID: <pub-id pub-id-type="pmid">28232871</pub-id></citation></ref>
<ref id="ref19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noworyta</surname> <given-names>K.</given-names></name> <name><surname>Cieslik</surname> <given-names>A.</given-names></name> <name><surname>Rygula</surname> <given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>Reinforcement-based cognitive biases as vulnerability factors in alcohol addiction: from humans to animal models</article-title>. <source>Br. J. Pharmacol.</source>, <fpage>179</fpage>, <fpage>4265</fpage>&#x2013;<lpage>4280</lpage>. doi: <pub-id pub-id-type="doi">10.1111/bph.15613</pub-id></citation></ref>
<ref id="ref20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noworyta</surname> <given-names>K.</given-names></name> <name><surname>Rygula</surname> <given-names>R.</given-names></name></person-group> (<year>2021</year>). <article-title>Phenotypes of reinforcement sensitivity as predictors of the response to acute antidepressant treatment in rats</article-title>. <source>Eur. Neuropsychopharmacol.</source> <volume>43</volume>, <fpage>102</fpage>&#x2013;<lpage>115</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.euroneuro.2020.12.004</pub-id>, PMID: <pub-id pub-id-type="pmid">33413909</pub-id></citation></ref>
<ref id="ref21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noworyta-Sokolowska</surname> <given-names>K.</given-names></name> <name><surname>Kozub</surname> <given-names>A.</given-names></name> <name><surname>Jablonska</surname> <given-names>J.</given-names></name> <name><surname>Rodriguez Parkitna</surname> <given-names>J.</given-names></name> <name><surname>Drozd</surname> <given-names>R.</given-names></name> <name><surname>Rygula</surname> <given-names>R.</given-names></name></person-group> (<year>2019</year>). <article-title>Sensitivity to negative and positive feedback as a stable and enduring behavioural trait in rats</article-title>. <source>Psychopharmacology</source> <volume>236</volume>, <fpage>2389</fpage>&#x2013;<lpage>2403</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00213-019-05333-w</pub-id>, PMID: <pub-id pub-id-type="pmid">31375849</pub-id></citation></ref>
<ref id="ref22"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Paxinos</surname> <given-names>G.</given-names></name> <name><surname>Watson</surname> <given-names>C.</given-names></name></person-group> (<year>1998</year>). <source>The Rat Brain in Stereotaxic Coordinates</source>, <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic Press</publisher-name></citation></ref>
<ref id="ref23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname> <given-names>B. U.</given-names></name> <name><surname>Dewan</surname> <given-names>S.</given-names></name> <name><surname>Nilsson</surname> <given-names>S. R. O.</given-names></name> <name><surname>Robbins</surname> <given-names>T. W.</given-names></name> <name><surname>Heath</surname> <given-names>C. J.</given-names></name> <name><surname>Saksida</surname> <given-names>L. M.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Selective effects of 5-HT2C receptor modulation on performance of a novel valence-probe visual discrimination task and probabilistic reversal learning in mice</article-title>. <source>Psychopharmacology</source> <volume>235</volume>, <fpage>2101</fpage>&#x2013;<lpage>2111</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00213-018-4907-7</pub-id>, PMID: <pub-id pub-id-type="pmid">29682701</pub-id></citation></ref>
<ref id="ref24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quesseveur</surname> <given-names>G.</given-names></name> <name><surname>Nguyen</surname> <given-names>H. T.</given-names></name> <name><surname>Gardier</surname> <given-names>A. M.</given-names></name> <name><surname>Guiard</surname> <given-names>B. P.</given-names></name></person-group> (<year>2012</year>). <article-title>5-HT2 ligands in the treatment of anxiety and depression</article-title>. <source>Expert Opin. Investig. Drugs</source> <volume>21</volume>, <fpage>1701</fpage>&#x2013;<lpage>1725</lpage>. doi: <pub-id pub-id-type="doi">10.1517/13543784.2012.719872</pub-id>, PMID: <pub-id pub-id-type="pmid">22917059</pub-id></citation></ref>
<ref id="ref25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raval</surname> <given-names>N. R.</given-names></name> <name><surname>Johansen</surname> <given-names>A.</given-names></name> <name><surname>Donovan</surname> <given-names>L. L.</given-names></name> <name><surname>Ros</surname> <given-names>N. F.</given-names></name> <name><surname>Ozenne</surname> <given-names>B.</given-names></name> <name><surname>Hansen</surname> <given-names>H. D.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>A single dose of psilocybin increases synaptic density and decreases 5-HT(2A) receptor density in the pig brain</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>:<fpage>835</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms22020835</pub-id>, PMID: <pub-id pub-id-type="pmid">33467676</pub-id></citation></ref>
<ref id="ref26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rygula</surname> <given-names>R.</given-names></name> <name><surname>Noworyta-Sokolowska</surname> <given-names>K.</given-names></name> <name><surname>Drozd</surname> <given-names>R.</given-names></name> <name><surname>Kozub</surname> <given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Using rodents to model abnormal sensitivity to feedback in depression</article-title>. <source>Neurosci. Biobehav. Rev.</source> <volume>95</volume>, <fpage>336</fpage>&#x2013;<lpage>346</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neubiorev.2018.10.008</pub-id>, PMID: <pub-id pub-id-type="pmid">30347197</pub-id></citation></ref>
<ref id="ref27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rygula</surname> <given-names>R.</given-names></name> <name><surname>Papciak</surname> <given-names>J.</given-names></name> <name><surname>Popik</surname> <given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Trait pessimism predicts vulnerability to stress-induced anhedonia in rats</article-title>. <source>Neuropsychopharmacology</source> <volume>38</volume>, <fpage>2188</fpage>&#x2013;<lpage>2196</lpage>. doi: <pub-id pub-id-type="doi">10.1038/npp.2013.116</pub-id>, PMID: <pub-id pub-id-type="pmid">23660704</pub-id></citation></ref>
<ref id="ref28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rygula</surname> <given-names>R.</given-names></name> <name><surname>Popik</surname> <given-names>P.</given-names></name></person-group> (<year>2016</year>). <article-title>Trait &#x201C;pessimism&#x201D; is associated with increased sensitivity to negative feedback in rats</article-title>. <source>Cogn. Affect. Behav. Neurosci.</source> <volume>16</volume>, <fpage>516</fpage>&#x2013;<lpage>526</lpage>. doi: <pub-id pub-id-type="doi">10.3758/s13415-016-0410-y</pub-id>, PMID: <pub-id pub-id-type="pmid">26902303</pub-id></citation></ref>
<ref id="ref29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Savitz</surname> <given-names>J.</given-names></name> <name><surname>Lucki</surname> <given-names>I.</given-names></name> <name><surname>Drevets</surname> <given-names>W. C.</given-names></name></person-group> (<year>2009</year>). <article-title>5-HT(1A) receptor function in major depressive disorder</article-title>. <source>Prog. Neurobiol.</source> <volume>88</volume>, <fpage>17</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.pneurobio.2009.01.009</pub-id>, PMID: <pub-id pub-id-type="pmid">19428959</pub-id></citation></ref>
<ref id="ref30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skandali</surname> <given-names>N.</given-names></name> <name><surname>Rowe</surname> <given-names>J. B.</given-names></name> <name><surname>Voon</surname> <given-names>V.</given-names></name> <name><surname>Deakin</surname> <given-names>J. B.</given-names></name> <name><surname>Cardinal</surname> <given-names>R. N.</given-names></name> <name><surname>Cormack</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Dissociable effects of acute SSRI (escitalopram) on executive, learning and emotional functions in healthy humans</article-title>. <source>Neuropsychopharmacology</source> <volume>43</volume>, <fpage>2645</fpage>&#x2013;<lpage>2651</lpage>. doi: <pub-id pub-id-type="doi">10.1038/s41386-018-0229-z</pub-id>, PMID: <pub-id pub-id-type="pmid">30305705</pub-id></citation></ref>
<ref id="ref31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>M. F.</given-names></name> <name><surname>Dong</surname> <given-names>J. Z.</given-names></name> <name><surname>Wang</surname> <given-names>Y. W.</given-names></name> <name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>Ju</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>CSF miR-16 is decreased in major depression patients and its neutralization in rats induces depression-like behaviors via a serotonin transmitter system</article-title>. <source>J. Affect. Disord.</source> <volume>178</volume>, <fpage>25</fpage>&#x2013;<lpage>31</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jad.2015.02.022</pub-id>, PMID: <pub-id pub-id-type="pmid">25779937</pub-id></citation></ref>
<ref id="ref32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Surowka</surname> <given-names>P.</given-names></name> <name><surname>Noworyta</surname> <given-names>K.</given-names></name> <name><surname>Cieslik</surname> <given-names>A.</given-names></name> <name><surname>Rygula</surname> <given-names>R.</given-names></name></person-group> (<year>2022</year>). <article-title>Trait sensitivity to negative feedback determines the effects of chronic stress and chronic mirtazapine treatment on anxiety and stress-coping strategies in rats</article-title>. <source>Psychopharmacology</source> <volume>239</volume>, <fpage>3975</fpage>&#x2013;<lpage>3984</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00213-022-06273-8</pub-id>, PMID: <pub-id pub-id-type="pmid">36352265</pub-id></citation></ref>
<ref id="ref33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Surowka</surname> <given-names>P.</given-names></name> <name><surname>Noworyta</surname> <given-names>K.</given-names></name> <name><surname>Rygula</surname> <given-names>R.</given-names></name></person-group> (<year>2020</year>). <article-title>Trait sensitivity to negative and positive feedback does not interact with the effects of acute antidepressant treatment on hedonic status in rats</article-title>. <source>Front. Behav. Neurosci.</source> <volume>14</volume>:<fpage>147</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnbeh.2020.00147</pub-id>, PMID: <pub-id pub-id-type="pmid">33061896</pub-id></citation></ref>
<ref id="ref34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor Tavares</surname> <given-names>J. V.</given-names></name> <name><surname>Clark</surname> <given-names>L.</given-names></name> <name><surname>Furey</surname> <given-names>M. L.</given-names></name> <name><surname>Williams</surname> <given-names>G. B.</given-names></name> <name><surname>Sahakian</surname> <given-names>B. J.</given-names></name> <name><surname>Drevets</surname> <given-names>W. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Neural basis of abnormal response to negative feedback in unmedicated mood disorders</article-title>. <source>NeuroImage</source> <volume>42</volume>, <fpage>1118</fpage>&#x2013;<lpage>1126</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.05.049</pub-id>, PMID: <pub-id pub-id-type="pmid">18586109</pub-id></citation></ref>
<ref id="ref35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vila-Ballo</surname> <given-names>A.</given-names></name> <name><surname>Mas-Herrero</surname> <given-names>E.</given-names></name> <name><surname>Ripolles</surname> <given-names>P.</given-names></name> <name><surname>Simo</surname> <given-names>M.</given-names></name> <name><surname>Miro</surname> <given-names>J.</given-names></name> <name><surname>Cucurell</surname> <given-names>D.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Unraveling the role of the hippocampus in reversal learning</article-title>. <source>J. Neurosci.</source> <volume>37</volume>, <fpage>6686</fpage>&#x2013;<lpage>6697</lpage>. doi: <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3212-16.2017</pub-id>, PMID: <pub-id pub-id-type="pmid">28592695</pub-id></citation></ref></ref-list></back></article>